{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:27:53Z","timestamp":1793392073654,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.chest.2021.05.027","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T23:52:58Z","timestamp":1621554778000},"page":"1915-1924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?"],"prefix":"10.1016","volume":"160","author":[{"given":"Nina","family":"Holling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Patole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.L.","family":"Medford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2021.05.027_bib1","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"suppl 2","key":"10.1016\/j.chest.2021.05.027_bib2","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2021.05.027_bib3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2021.05.027_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.chest.2021.05.027_bib5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs\u00a0chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.chest.2021.05.027_bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2021.05.027_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0463.2008.00005.x","article-title":"Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature","volume":"117","author":"Adiguzel","year":"2009","journal-title":"Apmis"},{"issue":"2","key":"10.1016\/j.chest.2021.05.027_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/108729104322802498","article-title":"Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review","volume":"18","author":"Waddington","year":"2004","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"10.1016\/j.chest.2021.05.027_bib9","first-page":"588","article-title":"Effective treatment of a patient with stage IV ovarian cancer: a case report","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.chest.2021.05.027_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/JTO.0b013e31817c606a","article-title":"Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion","volume":"3","author":"Niho","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10","key":"10.1016\/j.chest.2021.05.027_bib11","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.chest.2021.05.027_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/1061186X.2016.1200590","article-title":"Sequential treatment strategy for malignant pleural effusion in non-small cell lung cancer with the activated epithelial grow factor receptor mutation","volume":"25","author":"Lin","year":"2017","journal-title":"J\u00a0Drug Target"},{"issue":"37","key":"10.1016\/j.chest.2021.05.027_bib13","doi-asserted-by":"crossref","first-page":"62648","DOI":"10.18632\/oncotarget.16061","article-title":"Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"issue":"29","key":"10.1016\/j.chest.2021.05.027_bib14","doi-asserted-by":"crossref","first-page":"48521","DOI":"10.18632\/oncotarget.17952","article-title":"Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature","volume":"8","author":"Mori","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.chest.2021.05.027_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/resp.13812","article-title":"Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer","volume":"2511","author":"Chiang","year":"2020","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.chest.2021.05.027_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2021.05.027_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1513\/AnnalsATS.201811-786OC","article-title":"The prevalence and clinical relevance of non-expandable lung in malignant pleural\u00a0mesothelioma: a prospective, single-center cohort study of 229 patients","volume":"16","author":"Bibby","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.chest.2021.05.027_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR Clinical Practice Guideline.","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"issue":"6","key":"10.1016\/j.chest.2021.05.027_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1159\/000491097","article-title":"Effect of chemotherapy on removal of indwelling pleural catheters in breast cancer patients with malignant pleural effusions","volume":"96","author":"Mitchell","year":"2018","journal-title":"Respiration"},{"issue":"6-7","key":"10.1016\/j.chest.2021.05.027_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0959-8049(92)90459-F","article-title":"Increased myelosuppression during cytostatic treatment and pleural effusion\u00a0in patients with small cell lung cancer","volume":"28a","author":"Herrstedt","year":"1992","journal-title":"Eur J Cancer"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221009545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221009545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:39:16Z","timestamp":1757925556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221009545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0012369221009545"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.05.027","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}